Johnson & Johnson shares initially rose Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance. However, the stock pulled back and was down ...

To support the company's growth, Non-Executive Director Chris Hand was appointed chair on October 8, to lead Abingdon's operations whilst Chief Executive Officer Chris Yates leads the company's USA ...

Johnson & Johnson (NYSE:JNJ) lowered its full-year earnings outlook on Tuesday despite posting better-than-expected ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on third-quarter financial results and a surgical ...

Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company's exclusive sales and marketing partner for AmnioWrap2®</p ...

BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the ...

Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.

EDITEDtm, the leading global retail intelligence platform, today announced Mike MacKeen as the company's new Chief Financial Officer. MacKeen is a seasoned executive with deep operational and ...

Johnson & Johnson shares are up 3.1% in 2024, compared with the S&P 500 index's SPX gain of 22.9%. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is ...

AcuityMD, a leading technology provider to the medical technology (MedTech) industry, today announced the launch of AcuityMD ...

BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced its participation in the US Pharma Partnering ...

Johnson & Johnson's third-quarter performance exceeded expectations, with adjusted EPS of $2.42 against an expected $2.19.